Serdemetan

DB12027InvestigationalSmall molecule

Serdemetan has been used in trials studying the treatment of Neoplasms.

Chemical structure of Serdemetan
Formula / weight
C21H20N4 · 328.419 g/mol (avg)
Code names
JNJ-26854165

Resolves to

Compound
UNIIID6YB4W3V8CAS881202-45-5ChEMBLCHEMBL2137530PubChem11609586
Structure
InChIKeyCEGSUKYESLWKJP-UHFFFAOYSA-NSMILESC(CC1=CNC2=CC=CC=C12)NC1=CC=C(NC2=CC=NC=C2)C=C1
Targets
Q00987MDM2

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Serdemetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In